【Analyst Forecast】HEALIOS K.K.: Ordinary profit forecast for the fiscal year ending December 2026 down 2.6% from previous week (IFIS Stock Forecast)

HEALIOS's ordinary profit forecast for the year ending December 2026 fell 2.6% week on week to -¥3,746 million, while the rating consensus is expected to remain at 4.6.

Read in fullFrom the source, not the headline

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

HEALIOS's ordinary profit forecast for the year ending December 2026 fell 2.6% from -¥3,649 million the previous week to -¥3,746 million, according to reports. The rating consensus is also said to be unchanged at 4.6.

Related stocks cited include Qualipus, Chukyo Pharmaceutical, Eiken Chemical and Fuji Pharma. The article primarily reports the views of アイフィスジャパン.

At a glance

PeriodOrdinary profit forecast for the year ending December 2026

Amount-¥3,746 million

Change from previous reportDown 2.6% week on week

RatingRating consensus remains at 4.6

Related stocksQualipus, Chukyo Pharmaceutical, Eiken Chemical, Fuji Pharma

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

finance.yahoo.co.jpNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.